期刊文献+

骨桥蛋白在食管鳞癌中的表达及其临床意义 被引量:4

Expression and clinical significance of osteopontin in esophageal squamous cell carcinoma
下载PDF
导出
摘要 目的观察骨桥蛋白(OPN)在食管鳞癌组织、癌旁组织和转移淋巴结的表达状况,探讨OPN在食管鳞癌中表达的临床意义。方法运用免疫组化S-P法检测44例食管鳞癌组织、癌旁组织和20例转移淋巴结免疫组化染色。结果OPN在食管癌组织、癌旁组织及转移淋巴结中的表达率分别为86.3%、0%和100%。癌组织中OPN主要表达于肿瘤细胞的细胞浆中。OPN的表达与肿瘤TNM分期、淋巴结转移状态有关,而与肿瘤位置、肿瘤直径、浸润深度及病理学分级无关。OPN在癌组织、癌旁组织及转移淋巴结表达强度亦存在显著性差异。结论食管鳞癌组织中OPN主要由肿瘤细胞产生。OPN与肿瘤的浸润、转移有关,反映了肿瘤的生物学特性。 Objective To observe the expression of osteopontin (OPN) in tumor tissue, tumor adjacent tissue, and metastasized lymph nodes of esophageal squamous cell carcinoma, and to explore the relation between OPN and clinicopathological characteristics. Methods S-P staining was used to investigate the expression of OPN in 44 cases of the tumor tissue, 44 cases of the tumor adjacent tissue, and 20 cases of the metastasized lymph nodes of esophageal squamous cell carcinoma. Results The positive rate of OPN expression in tumor tissue, tumor adjacent tissue, and metastasized lymph nodes were 86.3%, 0%, and 100%, respectively. OPN was mainly distributed in cytoplasm of tumor cells and related with clinical stage and lymph node metastasis status, but not with tumor location, diameter, infiltration, or pathological grading. There was significant difference of OPN expression among tumor tissue, tumor adjacent tissue, and metastasized lymph nodes. Conclusion OPN is mainly produced by tumor cells and closely correlated to tumor progression.
出处 《免疫学杂志》 CAS CSCD 北大核心 2006年第6期678-680,共3页 Immunological Journal
关键词 骨桥蛋白 食管癌 鳞形细胞癌 免疫组化 Osteopontin Esophageal carcinoma Squamous cell carcinoma Immunohistochemistry
  • 相关文献

参考文献11

  • 1Casson AG,Wilson SM,McCart JA,et al.Ras mutation and expression of the ras-regulated genes osteopontin and cathepsin L in human esophageal cancer[J].Int J Cancer,1997,72(5):739-745.
  • 2Gillespie MT,Thomas RJ,Pu ZY,et al.Calcitonin receptors,bone sialoprotein and osteopontin are expressed in primary breast cancers[J].Int J Cancer,1997,73(6):812 -815.
  • 3Ue T,Yokozaki H,Kitadai Y,et al.Co-expression of osteopontin and CD44v9 in gastric cancer[J].Int J Cancer,1998,79 (2):127-132.
  • 4Khan SA,Lopez Chua CA,Zhang J,et al.Soluble osteopontin inhibits apoptosis of adherent endothelial cells deprived of growth factors[J].J Cell Biochem,2002,85 (4):728-736.
  • 5Rudland PS,Plat Higgins A,El Tanani M,et al.Prognostic significance of the metastasis-associated protein in human breast cancer[J].Cancer Res,2002,62(12):3 417 -3 427.
  • 6Nemoto H,Rittling SR,Yoshitake H,et al.Osteopontin deficiency reduces experimental tumor cell metastasis to bone and soft tissue[J].J Bone Miner Res,2001,16(4):652-659.
  • 7Weber GF.Meeting report:the next interleukin?[J].Sci STKE,2002,2002(147):PE37.
  • 8Irby RB,McCarthy SM,Yeatman TJ.Osteopontin regulates multiple functions contributing to human colon cancer development and progression[J].Clin Exp Metastasis,2004,21(6):515-523.
  • 9Bellahcene A,Castronovo V.Increased expression of osteonectin and osteopontin,two bone matrix proteins,in human breast cancer[J].Am J Pathol,1995,146(1):95-100.
  • 10Saitoh Y,Kuratsu J,Takeshima H,et al.Expression of osteopontin in human glioma.Its correlation with the malignancy[J].Lab Invest,1995,72(1):55-63.

同被引文献74

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部